Skip to main content
. 2021 Jan 14;13(1):99. doi: 10.3390/pharmaceutics13010099

Figure 5.

Figure 5

Hemolysis result of RBCs treated with RPTR-701Ns for; (A) 3 h and (B) 24 h.